OM and ME are firstly proved to have anti-Toxoplasma gondii activity in vitro and in vivo.
Both compounds showed effective protection to the liver damage caused by T. gondii in comparison to spiramycin.
OM and ME are likely the sources of new drugs for toxoplasmosis.